Analyst Price Targets — VGNT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 11:55 am | Bill Selesky | Argus Research | $54.00 | $45.43 | TheFly | Versigent price target raised to $54 from $50 at Argus |
| August 10, 2026 12:16 pm | Chris McNally | Evercore ISI | $65.00 | $43.41 | TheFly | Versigent price target raised to $65 from $60 at Evercore ISI |
| August 5, 2026 1:28 pm | — | Goldman Sachs | $59.00 | $45.62 | TheFly | Versigent price target raised to $59 from $48 at Goldman Sachs |
| August 5, 2026 1:17 pm | — | Deutsche Bank | $54.00 | $45.62 | TheFly | Versigent price target raised to $54 from $50 at Deutsche Bank |
| August 5, 2026 1:12 am | Tom Narayan | RBC Capital | $52.00 | $45.80 | TheFly | Versigent upgraded to Outperform from Sector Perform at RBC Capital |
| July 21, 2026 12:49 pm | — | Argus Research | $50.00 | $41.39 | TheFly | Versigent initiated with a Buy at Argus |
| July 21, 2026 11:53 am | — | Oppenheimer | $50.00 | $41.30 | StreetInsider | Argus Reiterates Buy Rating on Versigent Ltd. (VGNT) |
| July 20, 2026 12:50 am | — | Goldman Sachs | $48.00 | $40.01 | TheFly | Versigent initiated with a Buy at Goldman Sachs |
| July 13, 2026 12:52 pm | — | RBC Capital | $41.00 | $41.43 | TheFly | Versigent price target raised to $41 from $34 at RBC Capital |
| July 9, 2026 1:12 pm | — | UBS | $55.00 | $40.93 | TheFly | Versigent price target lowered to $55 from $58 at UBS |
Latest News for VGNT
Shares of Versigent (NYSE: VGNT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen ratings firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 12 month
Versigent delivered a strong first full quarter as an independent company, with sales up 10.8 percent and adjusted EBITDA up 24.8 percent. The stock is not as cheap as it was right after the Aptiv separation, but a valuation near 5.1 times expected 2026 adjusted EBITDA still looks reasonable. Debt and weak first-half cash conversion are the two issues I am watching most closely.
Versigent NYSE: VGNT reported second-quarter results marked by double-digit sales growth, higher adjusted EBITDA margins and the launch of its first quarterly dividend as the newly independent company navigates softer global vehicle production and elevated program-launch activity.
Versigent PLC (VGNT) Q2 2026 Earnings Call Transcript
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its second quarter ended June 30, 2026. Highlights Second Quarter 2026 Net sales of $2,444 million, up 10.8% year-over-year Adjusted Net Sales Growth1 of approximately 5% year-over-year Net income attributable to Versigent…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VGNT.
U.S. House Trading
No House trades found for VGNT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.